Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

Disproving the classical theory of protein folding phenomenon

Proteins are the messengers, workers, managers, and directors of mostly all intra- and inter-cellular functions in the human body.

7 Oct 2021

Radiation therapy can reprogram heart muscle cells to a younger state, suggests study

New research from Washington University School of Medicine in St. Louis suggests that radiation therapy can reprogram heart muscle cells to what appears to be a younger state, fixing electrical problems that cause a life-threatening arrhythmia without the need for a long-used, invasive procedure.

27 Sep 2021

Researchers show how 'bad mucin' contributes to worsening pulmonary conditions

Mucus is an essential protective layer of gel-like liquid composed largely of proteins called mucins throughout our airways.

23 Sep 2021

Potential biomarkers help diagnose progressive stages of liver disease

Results of national research pinpointed potential biomarkers that could ultimately be employed for the diagnosis of progressive stages of liver disease.

23 Sep 2021

Premature aging of the tracheobronchial stem cells could contribute to chronic lung disease

Are prematurely aged or overworked stem cells a significant factor in chronic lung disease? Findings of a study just released in STEM CELLS Translational Medicine (SCTM) say this is likely so.

22 Sep 2021

Combining bacteriophages with antibiotics to treat antibiotic-resistant infections

Mycobacterium abscessus, a relative of the bacteria that cause tuberculosis and leprosy, is responsible for particularly severe damage to human lungs and can be resistant to many standard antibiotics, making infections extremely challenging to treat.

17 Sep 2021

Scientists develop lung organoids to imitate actual SARS-CoV-2 infection

The emergence of the COVID-19 pandemic in the United States in early 2020 left researchers struggling to identify lab models of SARS-CoV-2 infection.

From UC San Diego 2 Sep 2021

Researchers use prime editing to correct mutations causing cystic fibrosis in organoids

A team of scientists rectified mutations that result in cystic fibrosis in cultured human stem cells.

11 Aug 2021

Specific subset of fibroblast cells could provide protection from debilitating lung disease

Single-cell RNA sequencing has revealed a subset of cells that could provide protection from a rare, but severely debilitating and fatal, lung disease.

16 Jul 2021

Cells damaged by chronic lung disease favor SARS-CoV-2 entry

Researchers propose that similar to pouring water atop a wellhead prior to pumping, the airway cells of patients suffering from chronic lung diseases are “primed” for infection by the COVID-19 virus.

16 Jul 2021

Liver fibrosis might be treatable with selective immunotoxins

Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.

13 Jul 2021

A new treatment approach against SARS-CoV-2

Scientists have come up with a new method to treat SARS-CoV-2 infection by fixing the cell damage instead of fighting the virus directly.

21 Jun 2021

Diet plays a crucial role in liver disease outcome, mouse model shows

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD patients are at higher risk of developing Non-alcoholic steatohepatitis (NASH), which causes severe and chronic liver inflammation, fibrosis and liver damage.

2 Jun 2021

Study shows potential of human mesenchymal stem cells in treating NTM lung infection

A study released today in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection.

5 May 2021

New gene editing approach bypasses disease-causing mutations

A new approach to gene editing using the CRISPR/Cas9 system bypasses disease-causing mutations in a gene, enabling treatment of genetic diseases linked to a single gene, such as cystic fibrosis, certain types of sickle cell anemia, and other rare diseases.

From Penn State University 22 Apr 2021

Fibrosis News and Research

Disproving the classical theory of protein folding phenomenon

Radiation therapy can reprogram heart muscle cells to a younger state, suggests study

Researchers show how 'bad mucin' contributes to worsening pulmonary conditions

Potential biomarkers help diagnose progressive stages of liver disease

Premature aging of the tracheobronchial stem cells could contribute to chronic lung disease

Combining bacteriophages with antibiotics to treat antibiotic-resistant infections

Scientists develop lung organoids to imitate actual SARS-CoV-2 infection

Researchers use prime editing to correct mutations causing cystic fibrosis in organoids

Specific subset of fibroblast cells could provide protection from debilitating lung disease

Cells damaged by chronic lung disease favor SARS-CoV-2 entry

Liver fibrosis might be treatable with selective immunotoxins

A new treatment approach against SARS-CoV-2

Diet plays a crucial role in liver disease outcome, mouse model shows

Study shows potential of human mesenchymal stem cells in treating NTM lung infection

New gene editing approach bypasses disease-causing mutations

New gene editor could help treat genetic disorders caused by single-nucleotide mutations

Researchers construct smallest and cheapest high-resolution microscope

Microfluidic chip and AI-based microscope help measure hemoglobin levels

New tool reveals potentially risky DNA alterations at site of CRISPR gene repair

Bernese researchers create sophisticated lung-on-chip

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics